Katja Lammens

Title: Katja Lammens: Innovator in Pharmaceutical Chemistry

Introduction

Katja Lammens is a notable inventor based in Gilching, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her work on the (S)-enantiomer of mepazine. Her innovative approach has implications for therapeutic applications, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Katja Lammens holds a patent for the (S)-enantiomer of mepazine. This invention relates to its applicability in therapy, a pharmacological composition comprising (S)-mepazine, and processes for the preparation of (S)-mepazine and one of its intermediates. This patent highlights her commitment to developing effective therapeutic solutions.

Career Highlights

Throughout her career, Katja has worked with prestigious institutions such as Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, and Ludwig-Maximilians-Universität München. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of her notable coworkers include Daniel Krappmann and Daniel Nagel. Their collaborative efforts have further enriched her research and innovation in pharmaceutical chemistry.

Conclusion

Katja Lammens is a pioneering inventor whose work on the (S)-enantiomer of mepazine exemplifies her significant contributions to the field of pharmaceutical chemistry. Her dedication to innovation continues to inspire advancements in therapeutic applications.